Potential genetic variants in schizophrenia: A Bayesian analysis

References

• Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jönsson EG. 2006. BDNF gene variants and brain morphology in schizophrenia, Am J Med Genet 141:513–523.
   Google Scholar
• Ahmadian A, Gharizadeh B, Gustafsson AC, Sterky F, Nyren P, Uhlen M, Lundeberg J. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000; 280: 103–110
   PubMed Web of Science ®Google Scholar
• Akahane A, Kunugi H, Tanaka H, Nanko S. Association analysis of polymorphic CGG repeat in 5′ UTR of the reelin and VLDLR genes with schizophrenia. Schizophr Res 2002; 58: 37–41
   Google Scholar
• American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, Third Edition – Revised. Washington, DC: American Psychiatric Association; 567 pp.
   Google Scholar
• American Psychiatric Association. 1995. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, International Version. Washington, DC: American Psychiatric Association; 900 pp.
   Google Scholar
• Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Rev 2000; 31: 106–112
   PubMedGoogle Scholar
• Arnborg S, Agartz I, Nordström M, Hall H, Sedvall G. Human Brain Informatics – understanding causes of mental illness. ERCIM News 2000; 3: 24–25
   Google Scholar
• Arnborg S, Agartz I, Hall H, Jönsson E, Sillén A, Sedvall G. Data mining in schizophrenia research – preliminary analysis. Principles of data mining and knowledge discovery, T Elomaa, H Mannila, H Toivonen. Springer, Berlin 2002; 2431: 27–38
   Google Scholar
• Caberlotto L, Hurd YL. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 2001; 25: 91–97
   PubMedGoogle Scholar
• Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004; 7: 575–580
   PubMed Web of Science ®Google Scholar
• Costa E, Chen Y, Davis J, Dong E, Noh JS, Tremolizzo L, Veldic M, Grayson DR, Guidotti A. Reelin and schizophrenia: A disease at the interface of the genome and the epigenome. Mol Intervent 2002; 2: 47–57
   PubMedGoogle Scholar
• Damberg M, Berggard C, Farde L, Sedvall GC, Jonsson EG. Transcription factor AP-2b genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. J Neural Transm 2004; 111: 537–545
   Google Scholar
• Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257–269
   PubMed Web of Science ®Google Scholar
• Ekholm B, Ekholm A, Adolfsson R, Vares M, Ösby U, Sedvall GC, Jönsson EG. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry 2005; 59: 457–464
   PubMed Web of Science ®Google Scholar
• Farde L, Hall H, Pauli S, Halldin C. Variability in D2-dopamine receptor density and affinity. A PET study with [11C]raclopride in man. Synapse 1995; 20: 200–208
   PubMed Web of Science ®Google Scholar
• Geijer T, Neiman J, Rydberg U, Gyllander A, Jonsson E, Sedvall G, Valverius P, Terenius L. Dopamine D2-Receptor gene polymorphisms in scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 1994; 244: 26–32
   PubMed Web of Science ®Google Scholar
• Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis2nd ed. Chapman & Hall, Boca Raton, FL 2004
   Google Scholar
• Gilks WR, Thomas A, Spiegelhalter DJ. A language and program for complex Bayesian modelling. The Statistician 1994; 43: 169–178
   Google Scholar
• Glatt SJ, Jönsson EG. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 149–154
   Google Scholar
• Glatt SJ, Faraone SV, Tsuang MT. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 2003; 8: 911–915
   Google Scholar
• Glatt SJ, Faraone SV, Tsuang MT. DRD2 -141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis. Am J Med Genet 2004; 128B: 21–23
   Google Scholar
• Hall H, McNeil T, Arnborg S, Agartz I, Ösby U, Linder J, Sedvall G. HUBIN – Human Brain Informatics: A clinical database project for multidisciplinary research in schizophrenia. Eur Psychiatry 2000; 15(Suppl 2)299s
   Google Scholar
• Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003; 361: 417–419
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40–68
   PubMed Web of Science ®Google Scholar
• Ilveskoski E, Kajander OA, Lehtimaki T, Kunnas T, Karhunen PJ, Heinala P, Virkkunen M, Alho H. Association of neuropeptide y polymorphism with the occurrence of type 1 and type 2 alcoholism. Alcohol Clin Exp Res 2001; 25: 1420–1422
   Google Scholar
• Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 15718–15723
   PubMed Web of Science ®Google Scholar
• Itokawa M, Arai M, Kato S, Ogata Y, Furukawa A, Haga S, Ujike H, Sora I, Ikeda K, Yoshikawa T. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett 2003; 347: 202–204
   PubMed Web of Science ®Google Scholar
• Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Åsberg M, Propping P, Sedvall GC. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr Res 1999; 40: 31–36
   PubMed Web of Science ®Google Scholar
• Jönsson EG, Sillén A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am J Med Genet 2003; 119B: 28–34
   Google Scholar
• Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B, Schumacher J, Cichon S, Agartz I, Sedvall GC, Hall H, Terenius L. 2006. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 30:924–933.
   PubMed Web of Science ®Google Scholar
• Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker JM, Hart LM, Valve R, Uusitupa MI. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 1998; 4: 1434–1437
   PubMed Web of Science ®Google Scholar
• Kauhanen J, Karvonen MK, Pesonen U, Koulu M, Tuomainen TP, Uusitupa MI, Salonen JT. Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. Am J Med Genet 2000; 93: 117–121
   Google Scholar
• Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck RA, Cramer J, Southwick S, Charney D, Krystal J, Gelernter J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry 2002; 59: 825–831
   PubMedGoogle Scholar
• Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM. 2005. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10:208–212.
   PubMed Web of Science ®Google Scholar
• Ohmori O, Shinkai T, Hori H, Kojima H, Nakamura J. Synapsin III gene polymorphisms and schizophrenia. Neurosci Lett 2000; 279: 125–127
   Google Scholar
• Ösby U, Correia N, Brandt L, Ekbom A, Sparen P. Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study. Br Med J 2000; 321: 483–484
   PubMed Web of Science ®Google Scholar
• Oxenstierna G, Bergstrand G, Edman G, Flyckt L, Nybäck H, Sedvall G. Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers. Eur Psychiatry 1996; 11: 16–20
   PubMed Web of Science ®Google Scholar
• Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science 2002; 296: 692–695
   PubMed Web of Science ®Google Scholar
• Schwab US, Agren JJ, Valve R, Hallikainen MA, Sarkkinen ES, Jauhiainen M, Karvonen MK, Pesonen U, Koulu M, Uusitupa MI, Savolainen MJ. The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet. Eur J Clin Nutr 2002; 56: 149–156
   Google Scholar
• Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59(Pt 1)97–105
   PubMedGoogle Scholar
• Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579–593
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R – Non Patient Version (SCID-NP). Biometrics Research Department, New York State Psychiatric Institute, New York 1986
   Google Scholar
• Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R – Patient Version (SCID-P). Biometrics Research Department, New York State Psychiatric Institute, New York 1988
   Google Scholar
• Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877–892.
   PubMed Web of Science ®Google Scholar
• Vares M, Ekholm A, Sedvall GC, Hall H, Jönsson EG. In press. Characterisation of patients with schizophrenia and related psychosis: evaluation of different diagnostic procedures. Psychopathology.
   Google Scholar
• Wassink TH, Nelson JJ, Crowe RR, Andreasen NC. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. Am J Med Genet 1999; 88: 724–728
   PubMedGoogle Scholar
• Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, Lindblom Y, Chowdari KV, Cardno AG, Zammit S, Jones LA, Murphy KC, Sanders RD, McCarthy G, Gray MY, Jones G, Holmans P, Nimgaonkar V, Adolfson R, Osby U, Terenius L, Sedvall G, O'Donovan MC, Owen MJ. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet 2003; 73: 1355–1367
   PubMed Web of Science ®Google Scholar
• Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589–593
   PubMed Web of Science ®Google Scholar